Flu News Friday: The Latest in Influenza Vaccines

The Influenzer Initiative
2 min readMar 13, 2020

--

March 13, 2020

Surveillance Update: 370,000 hospitalizations and 22,000 deaths including 144 pediatric deaths so far this season from influenza

1.Health Care Priorities For A COVID-19 Stimulus Bill: Recommendations To The Administration, Congress, And Other Federal, State And Local Leaders From Public Health, Medical, Policy And Legal Experts
Howard P. Forman, Elizabeth Fowler, Megan L. Ranney, Ruth J. Katz, Sara Rosenbaum, Kavita Patel,Timothy Stoltzfus Jost, Abbe R. Gluck, Christen Linke Young, Erica Turret, Suhas Gondi, Adam Beckman,
Health Affairs /March 12, 2020

Recommended under Vaccines, Treatment & Research:
New single-mission entity to develop a universal influenza vaccine. Provide support for the establishment of a new, independent, single-mission entity focused on accelerating the development of a universal influenza vaccine, to achieve global protection.

2.Immunogenicity, Safety, and Efficacy of a Standalone Universal Influenza Vaccine, FLU-v, in Healthy Adults: A Randomized Clinical Trial
Pleguezuelos O, et al, Annals of Internal Medicine/March 10, 2020

3. Is a ‘Universal’ Flu Vaccine on the Horizon?
Dennis Thompson, HealthDay Reporter,
U.S. News & World Report/ March 9, 2020

4.Watch: In prescient move, Bill Gates urged Trump to invest in pandemic preparedness two years ago
Rick Berke, STAT/March 10, 2020

Flickr: Gage Skidmore and OnInnovation

5.Thawing Permafrost Is Giving Scientists the Chance to Study Long-Dead Diseases
Marlene Cimons/Nexus Media, March 6, 2020

“Thawing permafrost on Herschel Island (Nunataryuk project)” by GRIDArendal is licensed under CC BY-ND 2.0

Visit Influenzer.org to learn more about our journey to accelerate the development of a universal influenza vaccine. @TheInfluenzers

--

--

The Influenzer Initiative
The Influenzer Initiative

Written by The Influenzer Initiative

Engaging and informing expertise from across research disciplines and industry sectors to drive innovation towards universal influenza vaccine development.

No responses yet